3-year (base year and 2 option years), firm fixed price task order for the mission and organizational support services to support the office of policy, legislation and international affairs (oplia)…

Active Awarded Last action

Contract number
75F40126F19038
Awardee
Awarding agency
Obligated
$1,294,786

Award facts

Contract value 46% obligated
  • $1,294,785.60 Current, with exercised options
  • $2,794,971.20 Potential, with all options
Completion date 2% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
Competitive 8(a)
Competition
Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration issued a $2.79 million delivery order to Kaiva Strategies, LLC, a tribally-owned, minority-owned 8(a) small business, on September 29, 2026, under the Competitive 8(a) Professional, Administrative, and Consulting Services (PACS) IDIQ to provide mission and organizational support services to FDA's Office of Policy, Legislation and International Affairs and Office of Global Policy and Strategy.

This is a three-year firm fixed price order (base year plus two option years) with an ultimate completion date of September 28, 2029. Place of performance is Silver Spring, MD. The order was issued under a competitive 8(a) set-aside. Kaiva Strategies operates primarily as a managed service delivery vehicle, with subcontractors performing approximately 70 percent of contractor hours across its SCI-reportable prime contracts, leveraging a deep bench of specialized labor partners.

Description

3-year (base year and 2 option years), firm fixed price task order for the mission and organizational support services to support the office of policy, legislation and international affairs (oplia) and office of global policy and strategy (ogps)

Quick answers

Who was awarded contract 75F40126F19038?

75F40126F19038 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on September 29, 2026.

How much is contract 75F40126F19038 worth?

The government has obligated $1,294,786 on 75F40126F19038. Its potential value, with all options, is $2,794,971.

Is contract 75F40126F19038 an order under another contract?

Yes. 75F40126F19038 is a delivery order under 75F40123D00021, an indefinite delivery contract.

Was contract 75F40126F19038 competed?

The extent of competition for 75F40126F19038 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award